Treatment of acquired partial oculomotor nerve palsy with dexamethasone - A case report.

Dexamethasone treatment Oculomotor nerve palsy Viral infection

Journal

International journal of surgery case reports
ISSN: 2210-2612
Titre abrégé: Int J Surg Case Rep
Pays: Netherlands
ID NLM: 101529872

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 01 08 2023
revised: 24 08 2023
accepted: 25 08 2023
medline: 7 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: ppublish

Résumé

Oculomotor nerve palsy is an acquired condition caused by injury to the third cranial nerve. Patients present classically with their eye in a "down and out" positioning, ptosis and abnormalities in most extraocular movements causing diplopia. Ocular dysfunction may be due to a variety of different etiologies, such as aneurysm, microvascular disease, trauma, and viral infections. Clinical prognosis is usually quite good and is often self-limiting. We present a case of an otherwise healthy 40-year-old male who awoke one morning with moderate diplopia, unable to focus with binocular vision and developed eyelid ptosis two days later. He was previously infected with the Omicron variant of COVID-19; however, a rapid test could not confirm it. No intracranial or vascular pathology were identified on CT head, CT angiogram, or MRI. Repeat COVID-19 PCR test was negative. He was assessed by a neuro-ophthalmologist and was diagnosed with left partial oculomotor nerve palsy presumed secondary to viral microvascular injury. COVID-19 infection seemed likely given the history but could not be confirmed. The specialist recommended monitoring the patient without any treatment, with no recommendation of corticosteroid use. Cranial neuropathy guidelines for viral palsies involving the 7th or 8th cranial nerve are treated with corticosteroids. After considering the risks, the patient elected treatment with a left eye patch and a dexamethasone taper. Full return of function in all extremes of gaze was restored less than 2 months after onset. Given the complete and timely recovery, it may be reasonable to consider corticosteroids for all cranial neuropathies.

Identifiants

pubmed: 37672829
pii: S2210-2612(23)00886-6
doi: 10.1016/j.ijscr.2023.108757
pmc: PMC10509868
pii:
doi:

Types de publication

Case Reports

Langues

eng

Pagination

108757

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The author(s) declare that the ideas in the submitted article are our own. We have no potential conflicts of interest to declare.

Références

Otolaryngol Head Neck Surg. 2019 Aug;161(1_suppl):S1-S45
pubmed: 31369359
Eye (Lond). 2015 Feb;29(2):246-51
pubmed: 25572578
Am J Ophthalmol. 1992 May 15;113(5):489-96
pubmed: 1575221
BMJ Case Rep. 2023 May 3;16(5):
pubmed: 37137545
Otolaryngol Head Neck Surg. 2013 Nov;149(3 Suppl):S1-27
pubmed: 24189771
Neurology. 2020 Aug 4;95(5):221-223
pubmed: 32358218
J Infect Public Health. 2021 Sep;14(9):1198-1200
pubmed: 34416597
Am J Case Rep. 2020 Oct 15;21:e925897
pubmed: 33056942
Somatosens Mot Res. 2019 Jun;36(2):102-108
pubmed: 31035834
J Fr Ophtalmol. 2020 Dec;43(10):e351-e353
pubmed: 33250085
Int J Surg. 2020 Dec;84:226-230
pubmed: 33181358
J Neuroophthalmol. 2021 Sep 1;41(3):e286-e287
pubmed: 33060468
Oman J Ophthalmol. 2016 May-Aug;9(2):80-6
pubmed: 27433033
Bosn J Basic Med Sci. 2022 Feb 01;22(1):39-45
pubmed: 34392827
Cureus. 2021 Apr 3;13(4):e14280
pubmed: 33959458

Auteurs

Cory Tremblay (C)

Northern Ontario School of Medicine University, 935 Ramsey Lake Rd, P3E 2C6, Sudbury, Ontario, Canada. Electronic address: cortremblay@nosm.ca.

Matthew Brace (M)

Department of Otolaryngology-Head & Neck Surgery, University of Toronto, 600 University Ave #401, M5G 1X5, Toronto, Ontario, Canada.

Classifications MeSH